Skip Navigation

Cardiovascular Research 1999 42(1):140-148; doi:10.1016/S0008-6363(98)00294-6
© 1999 by European Society of Cardiology
This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Finn, S. G.
Right arrow Articles by Fuller, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Finn, S. G.
Right arrow Articles by Fuller, S. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1999, European Society of Cardiology

G{alpha}13 stimulates gene expression and increases cell size in cultured neonatal rat ventricular myocytes

Stephen G. Finna, Steven G. Plonkb and Stephen J. Fullera,*

aCardiac Medicine, NHLI Division, Imperial College School of Medicine, London SW3 6LY, UK
bHoward Hughes Medical Institute, Department of Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, TN 37232, USA

* Corresponding author: Tel.: +44-171-352-8121; ext. 3309/3314; fax: +44-171-823-3392. E-mail address: stephen.fuller@ic.ac.uk

Received 23 March 1998; accepted 10 September 1998


   Abstract
Top
 Abstract
1 Introduction
 2 Methods
 3 Results
 4 Discussion
 References
 
Objectives: Constitutively-active G{alpha}13 causes permissive cell types to proliferate or undergo phenotypic transformation implying a role for G13 in the control of cell growth. Cardiac myocytes are terminally-differentiated cells which respond to growth stimuli by increasing in size rather than by cell division. The objective of this study was to determine whether constitutively-active G{alpha}13 is able to induce a hypertrophic phenotype in cardiac myocytes. Methods: Cultured neonatal rat ventricular myocytes were transiently transfected with an expression vector (pRC/RSV) encoding wild-type G{alpha}13 or constitutively-active G{alpha}13Q226L. Effects on transcription were monitored by co-transfected luciferase (LUX) reporter genes under the control of promoters responsive to hypertrophic stimuli. Cell size was determined by planimetry. Results: Transfection of neonatal myocytes with G{alpha}13Q226L, but not wild-type G{alpha}13, stimulated ANF638LUX and ANF3003LUX expression to 3.0±0.3- and 4.3±0.6-fold of the control, respectively. Likewise, G{alpha}13Q226L stimulated vMLC250LUX and vMLC2700LUX expression to 3.9±1.0- and to 7.7±1.7-fold of controls, respectively, but there was relatively little effect of G{alpha}13Q226L on c-fos-SRE- and β-MHC promoter activity. The effects of G{alpha}13Q226L on ANF3003LUX were inhibited by expression of C3 exoenzyme. Wild-type G{alpha}13 and G{alpha}13Q226L increased myocyte area from 869±43 µm2 in control transfections to 1287±64 µm2 and 1278±59 µm2, respectively. Conclusion: We conclude that G{alpha}13Q226L is able to induce gene expression and morphological changes associated with a hypertrophic response in cardiac myocytes and that the transcriptional effects may be mediated through a Rho-dependent mechanism.

KEYWORDS G-proteins; Myocytes; Rat; Signal transduction; Gene expression; Hypertrophy


   1 Introduction
Top
 Abstract
 1 Introduction
2 Methods
 3 Results
 4 Discussion
 References
 
As a consequence of their terminally differentiated phenotype, cardiac myocytes respond to growth stimuli by increasing their size rather than by undergoing cell division. Thus, whilst the oncogenic counterparts of cellular proto-oncogenes induce proliferation and phenotypic transformation (e.g. anchorage-independent growth) in many cell types, cardiac myocytes initiate a hypertrophic response. This is characterised by an increase in cell size, protein content and myofibrillar organization as well as specific changes in gene transcription (reviewed in Ref. [1]). The latter include a rapid and transient increase in the expression of immediate early genes (c-jun, c-fos and egr-1) [2, 3], the re-expression of atrial natriuretic factor (ANF), β-myosin heavy chain (β-MHC) and skeletal muscle {alpha}-actin and the upregulation of contractile protein genes such as ventricular myosin light chain-2 (vMLC2) and cardiac muscle {alpha}-actin.

Despite the different phenotypic responses (cell division, transformation or hypertrophy), common intracellular signalling pathways are frequently used to transduce the effects of growth stimuli on different cell types. In cardiac myocytes much recent attention has focused on the role of mitogen-activated protein kinases (MAPKs) as mediators of the hypertrophic response [4–10]. MAPKs are classified into the extracellularly regulated kinases (ERKs) and the stress-activated MAPKs, which themselves are subdivided into the c-Jun N-terminal kinases (JNKs) and the p38MAPKs. Broadly speaking, ERKs are activated by classical hypertrophic agonists such as phenylephrine (PE), endothelin-1 (ET-1) and 12-O-tetradecanoyl phorbol 13-acetate (TPA), whereas the stress-activated MAPKs, are activated more strongly by cell stresses such as ischaemia/reperfusion, osmotic shock and inhibitors of protein synthesis. Recent evidence points to a role for stress-activated MAPK activation in cardiac hypertrophy. Firstly, overexpression of MEKK1 or MKK7, upstream activators of the JNK pathway, induces transcriptional and morphological features of the hypertrophic response [7, 11]. Secondly, the JNK pathway is activated in the hypertrophied hearts of transgenic mice overexpressing oncogenic Ras [8]. Thirdly, overexpression of an upstream activator of p38MAPKβ induces a hypertrophic response [12]and SB 203580, a specific inhibitor of p38MAPK, inhibits the hypertrophic response to PE [10].

Guanine nucleotide-binding proteins (G proteins) play a central role in the signalling response to many extracellular stimuli. The G12 family is the most recently identified family of G proteins and consists of G12 and G13 [13]. The signal transduction pathways which G12 and G13 control are largely unknown but their role in cell growth is apparent from their ability to transform cells [14, 15]and to stimulate stress fibre formation [16]. In these G{alpha}13-transformed NIH 3T3 cells, expression of the primary response genes egr-1 and c-fos (both transcription factors) was constitutively-activated [15]. G{alpha}12 and G{alpha}13 robustly activate the JNK pathway but not the ERK pathway in NIH 3T3 cells [17]. The observations that G{alpha}12/G{alpha}13 induce JNK activation, initiate egr-1 and c-fos expression and regulate the actin cytoskeleton suggests a possible role in the development of cardiac hypertrophy, particularly in response to stress. Accordingly, we have determined the effects of G{alpha}13 on transcriptional and morphological markers of the hypertrophic response in cultured cardiac myocytes. We demonstrate that G{alpha}13 is able to induce genes associated with the hypertrophic phenotype and increase myocyte size. We propose that G{alpha}13 has the capacity to participate in the development of cardiac hypertrophy, particularly as a response to cellular stresses.


   2 Methods
Top
 Abstract
 1 Introduction
 2 Methods
3 Results
 4 Discussion
 References
 
The investigation conforms with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996).

Sprague-Dawley rats were bred within the National Heart and Lung Institute. Culture medium and other reagents were from Sigma Chemical (Poole, Dorset, U.K.), Marathon Laboratory Supplies (London, U.K.) or Merck (Lutterworth, Leics., U.K.), as described previously [18]. Endothelin-1 was from Bachem.

2.1 Expression and reporter plasmids
Murine G{alpha}13 was isolated by RT–PCR from liver RNA and subcloned into the expression vector pRC/RSV (Invitrogen). G{alpha}13Q226L harbours a point mutation which disables the intrinsic GTPase activity, resulting in a constitutively active construct. The rat ANF-luciferase (ANF-LUX) reporter constructs pANF(–638)L{Delta}5' (ANF638LUX) and pANF(–3003)L{Delta}5' (ANF3003LUX) [19], the vMLC2-LUX constructs pMLC(–250 to +18)L{Delta}5' (vMLC250LUX) and pMLC(–2700 to +18)L{Delta}5' (vMLC2700LUX) [20], and the Rous sarcoma virus (RSV)–LUX and pON249 [21]in which β-gal is expressed from a constitutive cytomegalovirus (CMV) promoter were kindly provided by Dr. K.R. Chien (Dept. of Medicine, University of California San Diego, CA). The AP-1-LUX construct TRE2PRL(-36) was a gift from Drs. J.H. Brown (Dept. of Pharmacology, University of California, San Diego, CA) and M.G. Rosenfeld (Howard Hughes Medical Institute, University of California, San Diego, CA). The LUX reporter constructs for rat β-MHC [22]and the mouse c-fos serum responsive element (c-fos-SRE) [23]were gifts from Dr. M.D. Schneider (Molecular Cardiology Unit, Baylor College of Medicine, Houston, TX) and have been described in detail previously [6]. The dominant-negative N17cdc42 and N17Rac1 constructs in the vector pRK5myc and the Rho inhibitor C3 exoenzyme in pEFmyc were provided by Prof. Alan Hall (MRC Laboratory for Molecular Cell Biology, University College London). Plasmids were purified by polyethylene glycol precipitation [24].

2.2 Transient transfection of cultured neonatal rat ventricular myocytes
Ventricular myocytes were isolated from the hearts of 1–2 day old rats as described previously [6]. Fibroblast contamination was reduced during a 30-min pre-plating and myocytes were subsequently plated on gelatin-coated 60-mm tissue culture dishes at a density of 1 million cells per dish (350 cells per mm2) for reporter gene experiments or at a density of 500 000 cells per 60-mm dish for assessment of cell size. Cells were maintained at 37°C in a humidified atmosphere of 5% CO2. Twenty hours after plating and 4 h before transfection, the medium was changed to 4% horse serum in maintenance medium (Dulbecco’s modified Eagle’s medium and medium 199 in a 4:1 ratio). Plasmids were diluted in 0.25 M CaCl2 and an equal volume of 50 mM N,N-bis(2-hydroxyethyl)-2-aminoethanesulphonic acid (pH 6.9), 280 mM NaCl, 1.5 mM Na2HPO4 was added. After 20 min, 0.5 ml of this suspension (containing 15 µg LUX reporter plasmid, 4 µg of pON249 and 0.3–10 µg of test plasmid, as indicated) was added to 4 ml of medium on each plate. After overnight transfection, cells were washed once with 10% horse serum in maintenance medium and twice with maintenance medium. Transfection efficiency assessed by 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal) staining of cells and light microscopy is routinely 1–2% by this method [6]but was not assayed here. After 48 h, myocytes were washed three times with ice-cold phosphate-buffered saline (PBS) and extracted on ice into 400 µl 0.1 M potassium phosphate (pH 7.9), 0.5% (v/v) Triton X-100, 1 mM dithiothreitol. Assays for LUX and β-gal were performed as detailed previously [6].

2.3 Determination of myocyte size
To assess the area of transfected myocytes, cells were transfected as above, except that myocytes were plated at a density of 0.5 million cells per dish to facilitate identification of individual cells. Cells were washed three times with ice-cold PBS, fixed with 4% formaldehyde in PBS for 10 min, re-washed three times with PBS and then stained with 0.2 mg/ml X-gal, 5 mM K4Fe(CN)6, 5 mM K3Fe(CN)6, 2 mM MgCl2 in PBS. After allowing colour to develop, transfected (blue) cells were randomly selected from all areas of the dishes and video hardcopies taken. Cell area was determined by planimetry.

2.4 Expression of results and statistical analysis
Results are expressed as the ratio of reporter gene expression in the presence of G{alpha}13 relative to empty vector controls. All transfection data was corrected for β-gal expression from the co-transfected pON249 plasmid. Results are presented as means ±S.E.M. for the number of separate myocyte preparations shown in the figure legends. Statistical significance was assessed by using a paired or unpaired Student’s t test, as appropriate, with a significant difference taken as being established at P<0.05.


   3 Results
Top
 Abstract
 1 Introduction
 2 Methods
 3 Results
4 Discussion
 References
 
3.1 Stimulation of ANF- and vMLC2 promoter activity by expression of constitutively-active G{alpha}13Q226L in neonatal myocytes
Transfection of neonatal myocytes with G{alpha}13Q226L caused a dose-dependent increase in LUX expression from a co-transfected ANF638LUX transgene (Fig. 1). Maximal expression was elicited with 3 µg G{alpha}13Q226L and this concentration was used in all subsequent studies. In contrast, there was little change in ANF-LUX expression with increasing concentrations of wild-type G{alpha}13 or backbone vector (Fig. 1). The proximal 638 bp of the rat ANF promoter is sufficient to confer selective upregulation in response to hypertrophic agonists in cardiac myocytes [19]. To determine if this promoter fragment was sufficient to transduce the full effect of G{alpha}13Q226L on ANF-LUX expression, the responses of ANF638LUX and ANF3003LUX were compared (Fig. 2). In this series of experiments G{alpha}13Q226L stimulated ANF638LUX expression to 3.0±0.3-fold of control and ANF3003LUX to 4.3±0.6-fold of control, but there was no significant difference in the extent of activation of these two promoter fragments. Transfection with wild-type G{alpha}13 had no effect on either promoter construct. A similar pattern was observed for vMLC2-LUX constructs (Fig. 3). Again, two promoter fragments were tested because, although the proximal 250 bp of the promoter is sufficient for tissue-specific and inducible expression of vMLC2-LUX transgenes [19], it is still possible that sequences in the promoter between –250 and –2700 harbour cis elements responsive to G{alpha}13Q226L. G{alpha}13Q226L stimulated vMLC250LUX and vMLC2700LUX expression to 3.9±1.0– and to 7.7±1.7-fold of controls, respectively, but these were not statistically different. There was no effect of wild-type G{alpha}13 on the 250 bp vMLC2 construct but expression of vMLC2700LUX was enhanced to 2.3±0.5-fold of control. Two additional control experiments were performed to determine that the effects of G{alpha}13Q226L on ANF- and vMLC2-LUX expression were specific (Fig. 4). Neither G{alpha}13Q226L nor wild-type G{alpha}13 had any effect on basal expression from the promoterless LUX vector pSVOAL{Delta}5' or on LUX expression driven by the constitutively-active Rous sarcoma virus (RSV) promoter. For comparison, it should be noted that basal LUX/β-gal expression from the RSV construct was 40.0±12.9-fold greater than that from ANF3003LUX (P<0.025) and 35.1±7.2-fold greater than that from vMLC250LUX (P<0.005). The effects of G{alpha}13Q226L were therefore specifically attributable to activation of the ANF and vMLC2 promoters.


Figure 1
View larger version (19K):
[in this window]
[in a new window]
[Download PowerPoint slide]
  		Fig. 1 Stimulation of ANF promoter activity by G{alpha}13Q226L. Neonatal cardiac myocytes were transfected with ANF638LUX (15 µg/dish), pON249 (4 µg/dish) and 0.3, 1, 3 or 10 µg of G{alpha}13 (closed triangles), G{alpha}13Q226L (open squares) or pRC/RSV backbone vector (open circles) as described under Section 2. After a further 48 h the cells were extracted and assayed for LUX expression. The results are the means from three separate myocyte preparations and are expressed relative to transfections with 0.3 µg of the control vector.

 

Figure 2
View larger version (21K):
[in this window]
[in a new window]
[Download PowerPoint slide]
  		Fig. 2 Stimulation of ANF638LUX and ANF3003LUX expression by G{alpha}13Q226L. Neonatal cardiac myocytes were transfected with ANF638LUX or ANF3003LUX (15 µg/dish), pON249 (4 µg/dish) and 3 µg of G{alpha}13, G{alpha}13Q226L or pRC/RSV backbone vector (CON) as described under Section 2. After a further 48 h the cells were extracted and assayed for LUX and β-gal expression. The results are the means±S.E.M. from five separate myocyte preparations and are expressed as LUX/β-gal activity ratios relative to transfections with the control vector. Statistical significance by paired t-test: a P<0.005, c P<0.01 versus control; b P<0.005, d P<0.02 versus G{alpha}13.

 

Figure 3
View larger version (19K):
[in this window]
[in a new window]
[Download PowerPoint slide]
  		Fig. 3 Stimulation of vMLC250LUX and vMLC2700LUX expression by G{alpha}13Q226L. Neonatal cardiac myocytes were transfected with vMLC250LUX or vMLC2700LUX (15 µg/dish), pON249 (4 µg/dish) and 3 µg of G{alpha}13, G{alpha}13Q226L or pRC/RSV backbone vector (CON) as described under Section 2. After a further 48 h the cells were extracted and assayed for LUX and β-gal expression. The results are the means±S.E.M. from nine (MLC2700) or ten (MLC250) separate myocyte preparations and are expressed as LUX/β-gal activity ratios relative to transfections with the control vector. Statistical significance by paired t-test: a P<0.02, c P<0.05, d P<0.005 versus control; b P<0.05, e P<0.02 versus G{alpha}13.

 

Figure 4
View larger version (23K):
[in this window]
[in a new window]
[Download PowerPoint slide]
  		Fig. 4 Effect of G{alpha}13Q226L on pSVOAL{Delta}5' and RSV-LUX expression. Neonatal cardiac myocytes were transfected with pSVOAL{Delta}5'or RSV-LUX (15 µg/dish), pON249 (4 µg/dish) and 3 µg of G{alpha}13, G{alpha}13Q226L or pRC/RSV backbone vector (CON) as described under Section 2. After a further 48 h the cells were extracted and assayed for LUX and β-gal expression. The results are the means±S.E.M. from four (pSVOAL{Delta}5') or seven (RSV) separate myocyte preparations. There were no significant differences between any of the transfections.

 
3.2 Stimulation of c-fos-SRE- and β-MHC promoter activity by G{alpha}13Q226L
In addition to ANF and vMLC2, several other genes are specifically activated in response to hypertrophic agonists including skeletal muscle {alpha}-actin, β-MHC and immediate-early genes such as c-fos, c-jun and Egr-1 [1]. Transfection with G{alpha}13Q226L had much smaller effects on LUX expression under the control of a c-fos-SRE promoter element or the β-MHC promoter (Fig. 5). Expression of the c-fos-SRE- and β-MHC-LUX constructs were only increased by 26% and 70%, respectively, though both effects were statistically significant. Treatment of myocytes transfected with the c-fos-SRE- and β-MHC-LUX constructs with TPA demonstrated that these transgenes were permissive to much stronger activation (4 to 5-fold) than that elicited by G{alpha}13Q226L (Fig. 5).


Figure 5
View larger version (27K):
[in this window]
[in a new window]
[Download PowerPoint slide]
  		Fig. 5 Stimulation of c-fos-SRE-LUX and β-MHC-LUX expression by G{alpha}13Q226L. Neonatal cardiac myocytes were transfected with c-fos-SRE-LUX or β-MHC-LUX (15 µg/dish), pON249 (4 µg/dish) and 3 µg of G{alpha}13, G{alpha}13Q226L or pRC/RSV backbone vector (CON) as described under Section 2. After a further 48 h in the presence or absence of TPA (1 µM), the cells were extracted and assayed for LUX and β-gal expression. Cells treated with TPA had been transfected with pRC/RSV. The results are the means±S.E.M. from 12 (β-MHC) or 13 (c-fos-SRE) separate myocyte preparations, except for experiments with TPA which were performed on six separate preparations. Statistical significance by paired t-test: a P<0.05, b P<0.005, c P<0.001, d P<0.02 versus control.

 
3.3 G{alpha}13Q226L does not stimulate AP-1-dependent promoter activity
As an extension of these studies we examined the effect of G{alpha}13Q226L on a LUX reporter construct under the control of two consensus TPA response elements (2xTRE) which bind the transcription factor AP-1, most usually composed of a c-Fos/c-Jun heterodimer. This construct (2xTRE) was completely unresponsive to G{alpha}13Q226L but was strongly activated by TPA (LUX/β-gal fold-induction for G{alpha}13Q226L and TPA were 0.85±0.14 (n=10) and 19.2±4.3 (n=5) relative to controls, respectively). Thus, G{alpha}13Q226L does not transactivate genes through an AP-1-dependent mechanism in cardiac myocytes.

3.4 G{alpha}13Q226L stimulation of transcription requires Rho but not Rac1 or cdc42
G{alpha}13 activates Rho in a wide variety of cell types and, since ANF-LUX expression in myocytes in response to PE is dependent on Rho [25, 26], we investigated whether Rho may mediate G{alpha}13Q226L-induced transcription of ANF-LUX (Fig. 6). Expression of C3 exoenzyme, which specifically ADP-ribosylates and inactivates Rho, prevented ANF-LUX induction in response to G{alpha}13Q226L. In contrast, no such inhibition was observed when dominant-negative constructs of two other members of the Rho family of GTPases, cdc42 and Rac1, were co-transfected with G{alpha}13Q226L, suggesting a specific role for Rho itself.


Figure 6
View larger version (17K):
[in this window]
[in a new window]
[Download PowerPoint slide]
  		Fig. 6 Inhibition of G{alpha}13Q226L-stimulated ANF3003LUX expression by C3 transferase. Neonatal cardiac myocytes were transfected with ANF3003LUX (15 µg/dish), pON249 (4 µg/dish), 3 µg of G{alpha}13Q226L (closed bars) or pRC/RSV backbone vector (open bars) and 3 µg of pEFmyc (pEF), pEFmyc-C3 transferase (C3), pRK5myc (pRK5), pRK5myc-N17cdc42 (N17cdc42) or pRK5myc-N17Rac1 (N17Rac1) as indicated, as described under Section 2. After a further 48 h the cells were extracted and assayed for LUX and β-gal expression. The results are the means S.E.M. from six separate myocyte preparations. Statistical significance by paired t-test: a P<0.02, b P<0.01 for effect of G{alpha}13Q226L versus pRC/RSV control; c P<0.01 for C3 versus pEF.

 
3.5 Na+/H+ exchanger activity is not required for G{alpha}13Q226L-induced ANF-LUX activity
G{alpha}13 activates Na+/H+ exchange in many cell types, an effect which may or may not be dependent on Rho [27]. Accordingly, to determine whether Na+/H+ activity may be required for G{alpha}13Q226L-induced transcription, myocytes were incubated with the Na+/H+ exchanger inhibitor 5-(N-ethyl-N-isopropyl) amiloride (EIPA). As shown in Fig. 7, EIPA (which inhibits the Na+/H+ exchanger with a Ki of 0.4 µM) failed to inhibit G{alpha}13Q226L-induced ANF-LUX expression at concentrations ranging from 1–16 µM. Indeed, at a concentration of 4 µM, EIPA actually increased ANF-LUX/β-gal in response to G{alpha}13Q226L, though basal ANF-LUX activity was also increased to a similar extent by EIPA in this series of experiments. In contrast, 4 µM EIPA almost completely inhibited ANF-LUX expression in response to PE.


Figure 7
View larger version (19K):
[in this window]
[in a new window]
[Download PowerPoint slide]
  		Fig. 7 G{alpha}13Q226L-stimulated ANF3003LUX expression is not inhibited by EIPA. (A) Neonatal cardiac myocytes were transfected with ANF3003LUX (15 µg/dish), pON249 (4 µg/dish) and 3 µg of G{alpha}13Q226L (closed bars) or pRC/RSV backbone vector (open bars) as described under Section 2. After a further 48 h in the presence or absence of EIPA at the concentration shown, the cells were extracted and assayed for LUX and β-gal expression. (B) Myocytes were transfected with ANF3003-LUX (15 µg/dish) and pON249 (4 µg/dish) and incubated in the presence (closed bars) or absence (open bars) of 100 µM PE and in the presence or absence of 4 µM EIPA. The results are the means±S.E.M. from five (A) or three (B) separate myocyte preparations. Statistical significance by paired t-test: a P<0.05, b P<0.02, c P<0.01 versus pRC/RSV in the absence of EIPA; d P<0.01 versus G{alpha}13Q226L in the absence of EIPA; e P<0.05 versus control; f P<0.05 versus no EIPA.

 
3.6 G{alpha}13Q226L induces morphological features characteristic of the hypertrophic phenotype in neonatal cardiac myocytes
Another characteristic feature of neonatal myocytes exposed to hypertrophic stimuli is their increased size [3, 6, 28]. Myocytes transfected with either wild-type G{alpha}13 (Fig. 8A, top right panel) or G{alpha}13Q226L (bottom left panel) were larger in cross-sectional area than the surrounding non-transfected cells. In contrast, myocytes transfected with the backbone vector were no different in size from the untransfected cells (top left panel). For comparison, cells in another dish were exposed to the powerful hypertrophic agonist ET-1, which increased the area of all the cells (bottom right panel). Quantitative analysis of 100 transfected cells determined that myocyte area was increased from 869±43 µm2 in control transfections to 1287±64 µm2 and 1278±59 µm2 in transfections with wild-type G{alpha}13 and G{alpha}13Q226L, respectively (Fig. 8B). The increase in area of G{alpha}13-transfected cells (47–48%) was similar to that in vector-transfected cells treated with ET-1 (54%, results not shown). Wild-type G{alpha}13 and G{alpha}13Q226L also increased the area/perimeter ratio, indicative of a more regular profile [18].


Figure 8
View larger version (75K):
[in this window]
[in a new window]
[Download PowerPoint slide]
  		Fig. 8 Effect of G{alpha}13 and G{alpha}13Q226L on myocyte size. Neonatal cardiac myocytes (5x105 cells per 60-mm culture dish) were transfected with pON249 (4 µg/dish) and 3 µg of G{alpha}13, G{alpha}13Q226L or pRC/RSV backbone vector (CON) as described under Section 2. After a further 48 h the cells were fixed and stained with X-Gal and cell area measured by planimetry. Results are means±S.E.M. from 100 randomly-chosen transfected cells. (A) Examples of myocytes transfected with backbone vector, G{alpha}13, G{alpha}13Q226L and backbone vector subsequently treated with 0.1 µM ET-1. Transfected myocytes are indicated by an arrow. Scale bar represents 100 µm. (B) Myocyte area. (C) Myocyte area/perimeter. Statistical significance: a p<0.001 versus control.

 

   4 Discussion
Top
 Abstract
 1 Introduction
 2 Methods
 3 Results
 4 Discussion
References
 
Heterotrimeric G proteins act as intermediates between receptors and second messenger systems. They are characterised by the distinct properties of their {alpha}-subunits and are classified into four families (Gs, Gi, Gq and G12) based on amino acid sequence homology (reviewed in [29, 30]). The G12 family is the most recently identified and consists of G12 and G13, which have been detected at both the mRNA and protein levels in a large number of tissues including the heart [13, 31, 32]. Their widespread distribution suggests that they may be involved in signal transduction pathways common to most tissues and their ability to transform cells [14, 15]points to a role in the regulation of cell growth. In this study we have demonstrated that G{alpha}13 can initiate a hypertrophic response in neonatal cardiac myocytes, characterised by upregulation of ANF-, vMLC2- and c-fos-SRE promoter activity and an increase in cell size.

The intracellular signalling pathways through which G{alpha}13 transduces its growth-promoting effects are still poorly understood. In many cell types Na+/H+ exchanger activity is a target for both G{alpha}12 and G{alpha}13 [33], though the isoforms involved and the consequences of their action may differ. Thus, whereas G{alpha}12Q229L inhibits NHE1 and activates NHE2 and NHE3, G{alpha}13Q226L activates all three isoforms [34]. Since NHE1 is the predominant isoform in the heart, G{alpha}13 may be expected to activate Na+/H+ exchanger activity more strongly than G{alpha}12 in this tissue. Activation of Na+/H+ exchanger activity leads to intracellular alkalinization which is a potent anabolic stimulus in the heart and in cardiac myocytes [35, 36]. However, stimulation of Na+/H+ exchange activity does not appear to be the mechanism through which G{alpha}13Q226L induces gene expression since this effect was not inhibited by EIPA but was somewhat augmented by it. In contrast, EIPA was able to inhibit PE-induced ANF expression, implying that this {alpha}1-adrenergic effect is dependent on Na+/H+ exchanger activity.

Another group of intracellular signalling pathways which are modulated by G{alpha}12 and G{alpha}13 [17, 37, 38]and which are important regulators of growth in a wide variety of cell types [39, 40]are the MAPK cascades. Transient transfection of NIH 3T3 [17]or COS-7 [38]cells with G{alpha}12Q229L or G{alpha}13Q226L activates the JNK pathway but not the ERK pathway. On the other hand, the ERK pathway can be activated by G{alpha}12 and G{alpha}13 in Rat-1 fibroblasts and both ERK and JNK activation appear to be required for mitogenesis in response to G{alpha}12 activation in NIH 3T3 fibroblasts [37, 41]. In cardiac myocytes there is a growing consensus that one or more MAPK pathways may be important in mediating the transcriptional and morphological responses to hypertrophic agonists [4–7, 9, 10, 18, 42–47]. Although activation of the ERK family of MAPKs was initially thought to be of paramount importance [4–6, 18, 44, 45], other more recent data suggests that activation the JNKs and p38MAPKs may be more closely associated with the hypertrophic response [7, 9, 10, 47]. Activation of the JNKs but not the ERKs [17, 38]by G{alpha}13Q226L would be consistent with a role for the stress-regulated MAPKs in the hypertrophic response.

The Rho family of GTPases includes Rho, Rac and cdc42 family members and there is increasing evidence that Rho plays an important role in the response of cardiac myocytes to hypertrophic agonists, perhaps in concert with MAPK pathway activation [25, 26, 48]. Myocytes infected with a recombinant adenovirus expressing constitutively activated Rho displayed enhanced ANF expression and increased assembly and organization of sarcomeric units, whereas expression of the Rho inhibitor C3 exoenzyme inhibited ANF expression and myofibrillar organization in response to PE [48]. The studies reported herein show that C3 exoenzyme is also able to inhibit G{alpha}13-induced ANF expression, suggesting that Rho is required for this response. In contrast, transfection with dominant-negative cdc42 and Rac1 constructs failed to inhibit G{alpha}13-induced ANF expression but this data should be viewed with caution since a dominant-negative Rho construct also failed to inhibit ANF expression significantly (data not shown). One possible explanation is that the dominant-negative constructs may be less effective since they act by mass action in binding the upstream Rho, cdc42 and Rac1 guanine nucleotide exchange factors, whereas the C3 exoenzyme will act catalytically to inhibit Rho directly. Hence, the current data support a role for Rho in G{alpha}13Q226L-mediated ANF expression but do not definitively rule out a potential role for the other Rho family members.

Little is known about the transcription factors which mediate the effects of the G12 family on gene expression. In NIH 3T3 cells transformed with G{alpha}13Q226L, early growth response gene-1 (egr-1) and c-fos are constitutively-active [15]. In the same cell type a constitutively-active G{alpha}12 mutant stimulated expression from an SRE-reporter gene [49], suggesting that activation of c-fos expression is most likely effected through the SRE in its promoter. Curiously, we observed only a small activation of a c-fos-SRE reporter gene by G{alpha}13Q226L, despite the ability of TPA to strongly activate it (Fig. 5). The reason for this difference is not clear but might involve tissue-specific differences in transcription factors. The β-MHC-LUX transgene was also only modestly upregulated by G{alpha}13Q226L, whereas the ANF- and vMLC2-LUX transgenes were strongly activated.

There were no significant differences in the degree of activation of the ANF638- and ANF3003-LUX constructs by G{alpha}13Q226L, indicating that the proximal 638 base pairs of the rat ANF promoter contains the cis elements necessary for induction by G{alpha}13Q226L. This region of the rat ANF promoter has many consensus sequence elements for binding transcription factors, including, egr-1, AP-1 and cAMP response element (CRE) motifs [19]. Different ANF promoter elements, including more specific cis sequences [50–52], appear to be responsible for ANF expression under a variety of experimental conditions [53], so any or several of these cis elements may be important. Since egr-1 is activated in G{alpha}13Q226L-transformed cells [15], this is one possibility. It is unlikely that the AP-1 site is important, however, because G{alpha}13Q226L failed to stimulate expression from a LUX reporter construct under the control of consensus AP-1 binding site. Furthermore, C3 exoenzyme does not inhibit PE-induced activation of this same AP-1 construct, whereas it does inhibit PE-induced ANF promoter activity [26]. Though there are several consensus cis elements within the vMLC250 and vMLC2700 promoter fragments [54], none are obvious candidates for activation by G{alpha}13Q226L.

As well as inducing the selective activation of marker genes for hypertrophy, overexpression of G{alpha}13Q226L increased myocyte size (Fig. 8). Interestingly, although wild-type G{alpha}13 was largely ineffective at inducing transcriptional responses, it was equally as effective as G{alpha}13Q226L in increasing myocyte size. This presumably reflects a low basal level of activity of G{alpha}13 which is sufficient to induce a response when overexpressed and suggests that cell size is more sensitive to G{alpha}13 than is transcription. It is not altogether surprising that wild-type G{alpha}13 can initiate a growth response in myocytes because even wild-type G{alpha}12 can transform NIH 3T3 cells when overexpressed, albeit at a much lower frequency than with G{alpha}12Q229L [55]. Overexpression of the {alpha} subunit of G13 will most likely disrupt the equilibrium between the {alpha} and β{gamma} subunits of G13 and in doing so may prolong the activity of G{alpha}13GTP, or may simply increase its concentration by a mass action effect. The mechanism for the effect of G{alpha}13 on cell size is not known, but, like its effect on transcription, may also be dependent on Rho family GTPases. Overexpression of constitutively-active Rho in myocytes by using a recombinant adenoviral vector increased sarcomeric organization [48], though a different study failed to detect any effect when recombinant constitutively active Rho protein was microinjected or expression plasmids were transfected [26]. Other processes such as phospholipase D (PLD) activation might also be important since hypertrophic agonists activate PLD in myocytes [56]and PLD activation by G{alpha}13Q226L is dependent on Rho GTPases [57].

Finally, the extracellular stimuli which may be coupled to a hypertrophic response through the G12 family of G proteins in cardiac myocytes are not known. Little information is available on what the upstream activators of G{alpha}12 and G{alpha}13 are in any cell type, but the best characterised system is in platelets where thrombin activates both G{alpha}12 and G{alpha}13 [58]. Thrombin has also been shown to activate ANF expression in myocytes [59], though it is not a classical hypertrophic agent. Another potential agonist is angiotensin II which initiates characteristic hypertrophic changes in cardiac myocytes [60]and which has been proposed to couple to increases in cytoplasmic Ca2+ in rat portal vein myocytes via G13 activation [61]. However, it is the β{gamma} subunits of G13 which are responsible for the Ca2+-elevating effect in the latter case.

In summary, we have shown that a GTPase-deficient mutant of G{alpha}13 is able to induce transcriptional and morphological features of the hypertrophic phenotype in cardiac myocytes. The mechanisms involved in transducing these effects of G{alpha}13 have not been unequivocally defined but most likely involve Rho, though activation of a number of other components including stress-activated MAPK pathways, PLD and other Rho family members may also be important. Upstream effectors which may elicit their hypertrophic effects through G{alpha}13 have still to be determined.

Time for primary review 28 days.


   Acknowledgements
 
This work was supported by grants BS1 and FS/96057 from the British Heart Foundation (to S.J.F.). We thank Ken Chien, Michael Schneider, Joan Heller Brown and Alan Hall for providing plasmids and Nicola Haward and Richard Taylor for preparation of the myocytes.


   References
Top
 Abstract
 1 Introduction
 2 Methods
 3 Results
 4 Discussion
 References
 

  1. Chien K.R., Knowlton K.U., Zhu H., Chien S. Regulation of cardiac gene expression during myocardial growth and hypertrophy: Molecular studies of an adaptive physiologic response. FASEB J (1991) 5:3037–3046.[Abstract]
  2. Iwaki K., Sukhatme V.P., Shubeita H.E., Chien K.R. {alpha}- and β-Adrenergic stimulation induces distinct patterns of immediate early gene expression in neonatal rat myocardial cells. fos/jun expression is associated with sarcomere assembly; Egr-1 induction is primarily a β1-mediated response. J Biol Chem (1990) 265:13809–13817.[Abstract/Free Full Text]
  3. Shubeita H.E., McDonough P.M., Harris A.N., et al. Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. A paracrine mechanism for myocardial cell hypertrophy. J Biol Chem (1990) 265:20555–20562.[Abstract/Free Full Text]
  4. Bogoyevitch M.A., Glennon P.E., Andersson M.B., et al. Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy. J Biol Chem (1994) 269:1110–1119.[Abstract/Free Full Text]
  5. Thorburn J., Frost J.A., Thorburn A. Mitogen-activated protein kinases mediate changes in gene expression, but not cytoskeletal organization associated with cardiac muscle cell hypertrophy. J Cell Biol (1994) 126:1565–1572.[Abstract/Free Full Text]
  6. Gillespie-Brown J., Fuller S.J., Bogoyevitch M.A., Cowley S., Sugden P.H. The mitogen-activated protein kinase kinase MEK1 stimulates a pattern of gene expression typical of the hypertrophic phenotype in rat ventricular cardiomyocytes. J Biol Chem (1995) 270:28092–28096.[Abstract/Free Full Text]
  7. Bogoyevitch M.A., Gillespie-Brown J., Ketterman A.J., et al. Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. Circ Res (1996) 79:162–173.[Abstract/Free Full Text]
  8. Ramirez M.T., Sah V.P., Zhao X.L., et al. The MEKK–JNK pathway is stimulated by {alpha}1-adrenergic receptor and Ras activation and is associated with in vitro and in vivo cardiac hypertrophy. J Biol Chem (1997) 272:14057–14061.[Abstract/Free Full Text]
  9. McDonough P.M., Hanford D.S., Sprenkle A.B., Mellon N.R., Glembotski C.C. Collaborative roles for c-Jun N-terminal kinase, c-Jun, serum response factor, and Sp1 in calcium-regulated myocardial gene expression. J Biol Chem (1997) 272:24046–24053.[Abstract/Free Full Text]
  10. Zechner D., Thuerauf D.J., Hanford D.S., McDonough P.M., Glembotski C.C. A role for the p38 mitogen-activated protein kinase pathway in myocardial cell growth, sarcomeric organization, and cardiac-specific gene expression. J Cell Biol (1997) 139:115–127.[Abstract/Free Full Text]
  11. Wang Y., Su B., Sah V.P., et al. Cardiac hypertrophy induced by mitogen-activated protein kinase kinase 7, a specific activator for c-Jun NH2-terminal kinase in ventricular muscle cells. J Biol Chem (1998) 273:5423–5426.[Abstract/Free Full Text]
  12. Wang Y.B., Huang S.A., Sah V.P., et al. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem (1998) 273:2161–2168.[Abstract/Free Full Text]
  13. Strathman M.P., Simon M.I. G{alpha}12 and G{alpha}13 subunits define a fourth class of G protein {alpha} subunits. Proc Natl Acad Sci USA (1991) 88:5582–5586.[Abstract/Free Full Text]
  14. Chan A.N.-L., Fleming T.P., McGovern E.S. Expression cDNA cloning of a transforming gene encoding the wild-type G alpha 12 gene product. Mol Cell Biol (1993) 13:762–768.[Abstract/Free Full Text]
  15. Prasad M.V.V.S.V., Shore S.K., Dhanasekaran N. Activated mutant of G{alpha}13 induces Egr-1, c-fos, and transformation in NIH 3T3 cells. Oncogene (1994) 9:2425–2429.[Web of Science][Medline]
  16. Buhl A.M., Johnson N.L., Dhanasekaran N., Johnson G.L. G{alpha}12 and G{alpha}13 stimulate Rho-dependent stress fiber formation and focal adhesion assembly. J Biol Chem (1995) 270:24631–24634.[Abstract/Free Full Text]
  17. Prasad M.V.V.S.V., Dermott J.M., Heasley L.E., Johnson G.L., Dhanasekaran N. Activation of Jun kinase/stress-activated protein kinase by GTPase-deficient mutants of G{alpha}12 and G{alpha}13. J Biol Chem (1995) 270:18655–18659.[Abstract/Free Full Text]
  18. Fuller S.J., Davies E.L., Gillespie-Brown J., Sun H., Tonks N.K. Mitogen-activated protein kinase phosphatase-1 inhibits the stimulation of gene expression by hypertrophic agonists in cardiac myocytes. Biochem J (1997) 323:313–319.[Web of Science][Medline]
  19. Knowlton K.U., Baracchini E., Ross R.S., et al. Co-regulation of the atrial natriuretic factor and cardiac myosin light chain-2 genes during {alpha}-adrenergic stimulation of neonatal rat ventricular cells. Identification of cis sequences within an embryonic and a constitutive contractile protein gene which mediate inducible expression. J Biol Chem (1991) 266:7759–7768.[Abstract/Free Full Text]
  20. Henderson S.A., Spencer M., Sen A., et al. Structure, organization, and expression of the rat cardiac myosin light chain-2 gene. Identification of a 250-base pair fragment which confers cardiac-specific expression. J Biol Chem (1989) 264:18142–18148.[Abstract/Free Full Text]
  21. Cherrington J.M., Mocarski E.S. Human cytomegalovirus ie1 transactivates the alpha promoter–enhancer via an 18-base-pair repeat element. J Virol (1989) 63:1435–1440.[Abstract/Free Full Text]
  22. Abdellatif M., MacLellan W.R., Schneider M.D. p21 Ras as a governor of global gene expression. J Biol Chem (1994) 269:15423–15426.[Abstract/Free Full Text]
  23. Parker T.G., Chow K.-L., Schwartz R.J., Schneider M.D. Positive and negative control of the skeletal {alpha}-actin promoter in cardiac muscle. A proximal serum response element is sufficient for induction by basic fibroblast growth factor (FGF) but not for inhibition by acidic FGF. J Biol Chem (1992) 267:3343–3350.[Abstract/Free Full Text]
  24. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor, New York, Cold Spring Harbor Laboratory Press, 1989.
  25. Sah V.P., Hoshijima M., Chien K.R., Brown J.H. Rho is required for G{alpha}q and {alpha}1-adrenergic receptor signaling in cardiomyocytes – Dissociation of Ras and Rho pathways. J Biol Chem (1996) 271:31185–31190.[Abstract/Free Full Text]
  26. Thorburn J., Xu S., Thorburn A. MAP kinase- and Rho-dependent signals interact to regulate gene expression but not actin morphology in cardiac muscle cells. EMBO J (1997) 16:1888–1900.[CrossRef][Web of Science][Medline]
  27. Hooley R., Yu C.Y., Symons M., Barber D.L. G alpha 13 stimulates Na+–H+ exchange through distinct Cdc42-dependent and RhoA-dependent pathways. J Biol Chem (1996) 271:6152–6158.[Abstract/Free Full Text]
  28. Clerk A., Gillespie-Brown J., Fuller S.J., Sugden P.H. Stimulation of phosphatidylinositol hydrolysis, protein kinase C translocation and mitogen-activated protein kinase activity by bradykinin in rat ventricular myocytes: dissociation from the hypertrophic response. Biochem J (1996) 317:109–118.[Web of Science][Medline]
  29. Fields T.A., Casey P.J. Signalling functions and biochemical properties of pertussis toxin-resistant G-proteins. Biochem J (1997) 321:561–571.[Web of Science][Medline]
  30. Neer E.J. Heterotrimeric G proteins: organizers of transmembrane signals. Cell (1995) 80:249–257.[CrossRef][Web of Science][Medline]
  31. Milligan G., Mullaney I., Mitchell F.M. Immunological identification of the {alpha} subunit of G13, a novel guanine nucleotide binding protein. FEBS Lett (1992) 297:186–188.[CrossRef][Web of Science][Medline]
  32. Spicher K., Kalkbrenner F., Zobel A., et al. G12 and G13 alpha-subunits are immunochemically detectable in most membranes of various mammalian cells and tissues. Biochem Biophys Res Commun (1994) 198:906–914.[CrossRef][Web of Science][Medline]
  33. Dhanasekaran N., Prasad M.V.V.S.V., Wadsworth S.J., Dermott J.M., Van Rossum G. Protein kinase C-dependent and -independent activation of Na+/H+ exchanger by G{alpha}12 class of G proteins. J Biol Chem (1994) 269:11802–11806.[Abstract/Free Full Text]
  34. Lin X., Voyno-Yasenetskaya T.A., Hooley R., et al. G alpha 12 differentially regulates Na+–H+ exchanger isoforms. J Biol Chem (1996) 271:22604–22610.[Abstract/Free Full Text]
  35. Sugden P.H., Fuller S.J. Correlations between cardiac protein synthesis rates, intracellular pH and the concentrations of creatine metabolites. Biochem J (1991) 273:339–346.[Web of Science][Medline]
  36. Gaitanaki C.J., Sugden P.H., Fuller S.J. Stimulation of protein synthesis by raised extracellular pH in cardiac myocytes and perfused hearts. FEBS Lett (1990) 260:42–44.[CrossRef][Web of Science][Medline]
  37. Voyno-Yasenetskaya T.A., Pace A.M., Bourne H.R. Mutant alpha subunits of G12 and G13 proteins induce neoplastic transformation of Rat-1 fibroblasts. Oncogene (1994) 9:2559–2565.[Web of Science][Medline]
  38. Voyno-Yasenetskaya T.A., Faure M.P., Ahn N.G., Bourne H.R. G{alpha}12 and G{alpha}13 regulate extracellular signal-regulated kinase and c-Jun kinase pathways by different mechanisms in COS-7 cells. J Biol Chem (1996) 271:21081–21087.[Abstract/Free Full Text]
  39. Force T., Pombo C.M., Avruch J.A., Bonventre J.V., Kyriakis J.M. Stress-activated protein kinases in cardiovascular disease. Circ Res (1996) 78:947–953.[Free Full Text]
  40. Robinson M.J., Cobb M.H. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol (1997) 9:180–186.[CrossRef][Web of Science][Medline]
  41. Mitsui H., Takuwa N., Kurokawa K., Exton J.H., Takuwa Y. Dependence of activated G{alpha}12-induced G1 to S phase cell cycle progression on both Ras/mitogen-activated protein kinase and Ras/Ras1/Jun N-terminal kinase cascades in NIH3T3 fibroblasts. J Biol Chem (1997) 272:4904–4910.[Abstract/Free Full Text]
  42. Bogoyevitch M.A., Glennon P.E., Sugden P.H. Endothelin-1, phorbol esters and phenylephrine stimulate MAP kinase activities in ventricular cardiomyocytes. FEBS Lett (1993) 317:271–275.[CrossRef][Web of Science][Medline]
  43. Lazou A., Bogoyevitch M.A., Clerk A., et al. Regulation of the mitogen-activated protein kinase cascade in adult rat heart preparations in vitro. Circ Res (1994) 75:932–941.[Abstract/Free Full Text]
  44. Glennon P.E., Kaddoura S., Sale E.M., et al. Depletion of mitogen-activated protein kinase using an antisense oligodeoxynucleotide approach down regulates the phenylephrine-induced hypertrophic response in rat cardiac myocytes. Circ Res (1996) 78:954–961.[Abstract/Free Full Text]
  45. Sadoshima J., Qiu Z., Morgan J.P., Izumo S. Angiotensin II and other hypertrophic stimuli mediated by G protein-coupled receptors activate tyrosine kinase, mitogen-activated protein kinase, and 90-kD S6 kinase in cardiac myocytes: The critical role of Ca2+-dependent signaling. Circ Res (1995) 76:1–15.[Abstract/Free Full Text]
  46. Thorburn J., Carlson M., Mansour S.J., et al. Inhibition of a signaling pathway in cardiac muscle cells by active mitogen-activated protein kinase. Mol Biol Cell (1995) 6:1479–1490.[Abstract]
  47. Post G.R., Goldstein D., Thuerauf D.J., Glembotski C.C., Brown J.H. Dissociation of p44 and p42 mitogen-activated protein kinase activation from receptor-induced hypertrophy in neonatal rat ventricular myocytes. J Biol Chem (1996) 271:8452–8457.[Abstract/Free Full Text]
  48. Hoshijima M., Sah V.P., Wang Y., Chien K.R., Brown J.H. The low molecular weight GTPase Rho regulates myofibril formation and organization in neonatal rat ventricular myocytes involvement of Rho kinase. J Biol Chem (1998) 273:7725–7730.[Abstract/Free Full Text]
  49. Fromm C., Coso O.A., Montaner S., Xu N.Z., Gutkind J.S. The small GTP-binding protein Rho links G protein-coupled receptors and G{alpha}12 to the serum response element and to cellular transformation. Proc Natl Acad Sci USA (1997) 94:10098–10103.[Abstract/Free Full Text]
  50. Ardati A., Nemer M. A nuclear pathway for {alpha}1-adrenergic receptor signaling in cardiac cells. EMBO J (1993) 12:5131–5139.[Web of Science][Medline]
  51. Harris A.N., Ruiz-Lozano P., Chen Y.F., et al. A novel A/T-rich element mediates ANF gene expression during cardiac myocyte hypertrophy. J Mol Cell Cardiol (1997) 29:515–525.[CrossRef][Web of Science][Medline]
  52. Sprenkle A.B., Murray S.F., Glembotski C.C. Involvement of multiple cis elements in basal- and {alpha}-adrenergic agonist-inducible atrial natriuretic factor transcription. Roles for serum response elements and an SP-1-like element. Circ Res (1995) 77:1060–1069.[Abstract/Free Full Text]
  53. Knowlton K.U., Rockman H.A., Itani M., et al. Divergent pathways mediate the induction of ANF transgenes in neonatal and hypertrophic ventricular myocardium. J Clin Invest (1995) 96:1311–1318.[Web of Science][Medline]
  54. Zhu H., Garcia A.V., Ross R.S., Evans S.M., Chien K.R. A conserved 28-base-pair element (HF-1) in the rat cardiac myosin light-chain-2 gene confers cardiac-specific and alpha-adrenergic-inducible expression in cultured neonatal rat myocardial cells. Mol Cell Biol (1991) 11:2273–2281.[Abstract/Free Full Text]
  55. Voyno-Yasenetskaya T., Conklin B.R., Gilbert R.L., et al. G{alpha}13 stimulates Na+–H+ exchange. J Biol Chem (1994) 269:4721–4724.[Abstract/Free Full Text]
  56. Clerk A., Sugden P.H. Regulation of phospholipases C and D in rat ventricular myocytes: Stimulation by endothelin-1, bradykinin and phenylephrine. J Mol Cell Cardiol (1997) 29:1593–1604.[CrossRef][Web of Science][Medline]
  57. Plonk S.G., Park S.-K., Exton J.H. The {alpha}-subunit of the heterotrimeric G protein G13 activates a phospholipase D isozyme by a pathway requiring Rho family GTPases. J Biol Chem (1998) 273:4823–4826.[Abstract/Free Full Text]
  58. Offermanns S., Laugwitz K.L., Spicher K., Schultz G. G proteins of the G12 family are activated via thromboxane A2 and thrombin receptors in human platelets. Proc Natl Acad Sci USA (1994) 91:504–508.[Abstract/Free Full Text]
  59. Glembotski C.C., Irons C.E., Krown K.A., et al. Myocardial {alpha}-thrombin receptor activation induces hypertrophy and increases atrial natriuretic factor gene expression. J Biol Chem (1993) 268:20646–20652.[Abstract/Free Full Text]
  60. Sadoshima J., Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res (1993) 73:413–423.[Abstract/Free Full Text]
  61. Macrez-LeprLtre N., Kalkbrenner F., Morel J.L., Schultz G., Mironneau J. G protein heterotrimer G{alpha}13β1gamma3 couples the angiotensin AT1A receptor to increases in cytoplasmic Ca2+ in rat portal vein myocytes. J Biol Chem (1997) 272:10095–10102.[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Circ. Res.Home page
J. H. Brown, D. P. Del Re, and M. A. Sussman
The Rac and Rho Hall of Fame: A Decade of Hypertrophic Signaling Hits
Circ. Res., March 31, 2006; 98(6): 730 - 742.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
N. Wettschureck and S. Offermanns
Mammalian G Proteins and Their Cell Type Specific Functions
Physiol Rev, October 1, 2005; 85(4): 1159 - 1204.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
R. Kacimi and A. M. Gerdes
Alterations in G Protein and MAP Kinase Signaling Pathways During Cardiac Remodeling in Hypertension and Heart Failure
Hypertension, April 1, 2003; 41(4): 968 - 977.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
Y. Maruyama, M. Nishida, Y. Sugimoto, S. Tanabe, J. H. Turner, T. Kozasa, T. Wada, T. Nagao, and H. Kurose
G{alpha}12/13 Mediates {alpha}1-Adrenergic Receptor-Induced Cardiac Hypertrophy
Circ. Res., November 15, 2002; 91(10): 961 - 969.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. S. Kapiloff
Contributions of Protein Kinase A Anchoring Proteins to Compartmentation of cAMP Signaling in the Heart
Mol. Pharmacol., August 1, 2002; 62(2): 193 - 199.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
G. P. van Nieuw Amerongen and V. W.M. van Hinsbergh
Cytoskeletal Effects of Rho-Like Small Guanine Nucleotide-Binding Proteins in the Vascular System
Arterioscler Thromb Vasc Biol, March 1, 2001; 21(3): 300 - 311.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Finn, S. G.
Right arrow Articles by Fuller, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Finn, S. G.
Right arrow Articles by Fuller, S. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?